Table 4.
Effect of FRG supplementation on lipid levels
| |
Placebo group (n = 21) |
FRG group (n = 21) |
p-
value
2)
|
||||
|---|---|---|---|---|---|---|---|
| Baseline | Week 4 | p- value 1) | Baseline | Week 4 | p- value 1) | ||
| Total cholesterol (mmol/l) |
4.9 ± 0.2 |
4.8 ± 0.2 |
NS |
5.4 ± 0.2 |
4.9 ± 0.2 |
0.008 |
NS |
| HDL cholesterol (mmol/l) |
1.2 ± 0.1 |
1.1 ± 0.1 |
0.022 |
1.3 ± 0.1 |
1.2 ± 0.1 |
0.014 |
NS |
| LDL cholesterol (mmol/l) |
3.1 ± 0.2 |
2.8 ± 0.2 |
0.005 |
3.3 ± 0.2 |
2.9 ± 0.2 |
0.025 |
NS |
| Triglycerides (mmol/l) | 1.6 ± 0.2 | 1.7 ± 0.2 | NS | 1.6 ± 0.2 | 1.9 ± 0.2 | NS | NS |
1)Analyzed by linear mixed effect model and p-value represents the comparison to the baseline visit. 2)Analyzed by linear mixed effect model and p-value represents the comparison to the placebo group. Data are presented as mean ± SEM.